FORESITE CAPITAL
Foresite Capital their funding includes developing generation therapeutics.
FORESITE CAPITAL
Industry:
Finance Financial Services Funding Platform Service Industry Venture Capital
Founded:
2011-01-01
Status:
Active
Contact:
+1 415-877-4887
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
1315 Capital
1315 Capital provides expansion and growth capital to commercial stage pharmaceuticals, medical technologies, and healthcare services.
Haystack
Haystack is a venture capital firm that backs outlier founders at the earliest stages.
Highlight Capital
Highlight Capital is an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect.
Marquette Capital Partners
Marquette Capital provides flexible junior capital solutions in support of lower-middle-market companies throughout the United States.
Patriot Capital
Patriot Capitalย provides debt and equity capital in acquisitions, management buyouts and recapitalizations.
SaaS Capital
Premier provider of alternative growth capital to growing SaaS companies.
Current Advisors List
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-07-18 | Delfi Diagnostics | Foresite Capital investment in Series B - Delfi Diagnostics | 225 M USD |
2022-06-21 | Myome | Foresite Capital investment in Series B - Myome | 23 M USD |
2022-05-17 | Mirvie | Foresite Capital investment in Series B - Mirvie | 45 M USD |
2022-05-17 | Remix Therapeutics | Foresite Capital investment in Series B - Remix Therapeutics | 70 M USD |
2022-05-16 | Kriya Therapeutics | Foresite Capital investment in Series C - Kriya Therapeutics | 270 M USD |
2022-03-08 | DNAnexus | Foresite Capital investment in Series H - DNAnexus | 200 M USD |
2022-01-27 | TenSixteen Bio | Foresite Capital investment in Series A - TenSixteen Bio | 40 M USD |
2022-01-20 | ImmPACT Bio | Foresite Capital investment in Series B - ImmPACT Bio | 111 M USD |
2022-01-10 | Maze Therapeutics | Foresite Capital investment in Venture Round - Maze Therapeutics | 190 M USD |
2022-01-06 | Eikon Therapeutics | Foresite Capital investment in Series B - Eikon Therapeutics | 518 M USD |
More informations about "Foresite Capital"
Foresite Capital - Wikipedia
Foresite Capital (Foresite) is an American, multi-stage healthcare and life sciences investment firm headquartered in Los Angeles, and with offices in The San Francisco Bay Area and New York City. As of June 2024, the company had raised six primary funds: Foresite Capital Fund I, II, III, IV, V and VI. See details»
Foresite Capital - Crunchbase Investor Profile
Foresite Capital closed a $900 million life sciences venture fund and raised $900 million to invest in healthcare and life science startups at all stages. Additionally, Foresite Capital executives invested $40 million in Alumis Inc.See details»
Foresite Capital - Investments, Portfolio & Company Exits
Nov 18, 2024 Foresite Capital has made 167 investments. Their most recent investment was โฆSee details»
Foresite raises $900M to make fresh set of big biotech โฆ
Jun 12, 2024 Foresite Capital CEO Jim Tananbaum, M.D., says weโre in โone of the best biotech investment environmentsโ of his multidecade careerโand has rounded up $900 million to put that belief to ...See details»
Foresite Capital raises $900M sixth fund for investing in
Jun 12, 2024 On Wednesday, Foresite announced that it closed its sixth fund with $900 โฆSee details»
Foresite Capital Raises $900M to Invest in Healthcare โฆ
SAN FRANCISCO, June 12, 2024--Foresite Capital, a multi-stage healthcare and life sciences investment firm with more than $3.5 billion under management, announced today that it has closed its ...See details»
Foresite Capital Raises $969 Million to Invest in Early to Late-Stage ...
Feb 25, 2021 Foresite Capital announces that it has raised $969 million to invest in life โฆSee details»
Flush with Cash, Foresite Aims to Live Up to Its Name
Feb 25, 2021 Foresite Capital intends to add to its portfolio of successful startups through a pair of new funds totaling nearly $969 million.See details»
Foresite Capital raises $969 million fund to invest in โฆ
Feb 25, 2021 Health and life science specialist investment firm Foresite Capital has raised a new fund, its fifth to date, totaling $969 million in commitments fromSee details»
Foresite raises $900M to make big bets in โone of ... - Foresite Capital
Jun 12, 2024 Foresite Capital is an investment firm that aims to transform healthcare by โฆSee details»
Foresite Capital Raises $969 Million to Invest in Early to Late-Stage ...
Feb 25, 2021 With ~ $4B in assets under management, Foresite Capital raises its largest โฆSee details»
Foresite Capital Raises $900M to Invest in Healthcare and Life โฆ
Jun 12, 2024 Foresite Capital, a multi-stage healthcare and life sciences investment firm with โฆSee details»
Foresite Capital Closes $900 Million Fund VI to Invest in Healthcare ...
Jun 12, 2024 Foresite Capital concludes its sixth fund, aiming to invest in cutting-edge โฆSee details»
Foresite, a biotech venture firm, reloads with $900M fund
Jun 12, 2024 Foresite Capital, an investment firm that backs life sciences and healthcare โฆSee details»
Foresite Capital Portfolio Companies - Crunchbase
Jan 6, 2014 Foresite Capital is a healthcare and life sciences investment firm. This list of โฆSee details»
Foresite Capital Raises $668 Million Fund IV
May 3, 2018 New fund raises total assets under management to $2B as firm expands its data โฆSee details»
Foresite Capital Company Profile - Office Locations ... - Craft
Foresite Capital has 5 employees across 3 locations. See insights on Foresite Capital including โฆSee details»
Stephen C. Peterson, CFA - Foresite Capital
Stephen began his investment career as an analyst with Wells Fargo. In addition to his work โฆSee details»
Foresite Capital - Crunchbase
Foresite Capital is a healthcare and life sciences investment firm.See details»